Pharmacokinetics of Oral Calcium Carbonate in Parturients

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

October 31, 2025

Conditions

PregnancyPharmacokineticsPostpartum Hemorrhage

Interventions

DRUG

Oral calcium carbonate

All participants receive a single, open-label dose of oral calcium carbonate 3000mg

Trial Locations (1)

Stanford Children's Health, Lucile Packard Children's Hospital, Stanford

All Listed Sponsors

lead

Stanford University

OTHER